However, the deeper mechanism by which hID2 modulates the NF-κB pathway needs further investigation, and more animal models, such as DSS-induced chronic colitis and T cell transfer-induced colitis, are warranted to further assess the role of the hID2 protein in the treatment of UC. Here, NFKB1 is linked to Chronic colitis.